Rationale for concurrent chemoradiotherapy for patients with stage ...

When treating patients with unresectable stage III non-small-cell lung cancer (NSCLC), those with a good performance status and disease measured within a ...

When treating patients with unresectable stage III non-small-cell lung cancer (NSCLC), those with a good performance status and disease ...

Rationale and Design of the Phase 3 KEYLYNK-013 ... - PubMed

Abstract · Background: The current standard of care for patients with newly diagnosed limited-stage small-cell lung cancer (SCLC) is concurrent chemoradiotherapy ...

Rationale and Design of the Phase III KEYLYNK-012 Study of ...

Concurrent chemoradiotherapy is a standard therapy for patients with stage III non-small-cell lung cancer (NSCLC). Durvalumab is an approved ...

Rationale for concurrent chemoradiotherapy for patients with stage ...

Modern advances in radiotherapy treatment planning software and treatment delivery mean that radiation oncologists can safely treat substantially larger ...

Chemoradiotherapy in Cancer Treatment: Rationale and Clinical ...

The addition of concurrent chemotherapy increases radiotherapy efficacy as indicated by the green arrows shifting both curves to the left. A stronger shift is ...

Rationale and Design of the Phase III KEYLYNK-012 Study of ...

Stage III non-small-cell lung cancer (NSCLC) is commonly treated with concurrent chemoradiotherapy (CCRT). ... For patients without disease progression following ...

Concurrent chemoradiotherapy for stage III non-small-cell lung cancer

Several clinical studies and meta-analyses have documented concomitant chemoradiotherapy (CHRT) as the most effective definitive treatment in locally advanced ...

Outcomes of concurrent chemoradiotherapy in patients with stage III ...

Conclusions: Patients with significant comorbidity who are fit to undergo cisplatin-based CCRT achieve median survivals similar to that reported in phase III ...

Phase III Study of Surgery Versus Definitive Concurrent ...

Concurrent chemoradiotherapy with or without surgery are options for stage IIIA(N2) non–small-cell lung cancer. Our previous phase II study ...

Concurrent chemoradiotherapy for cervical cancer

However,most positive trials of CCRT had small percentages of patients with stage Ⅲ-Ⅳ disease. In contrast,fewer than 16% of Japanese institutions offer CCRT to ...

an open-label, phase 3, randomised, superiority trial - The Lancet

Concurrent chemoradiotherapy is the standard of care in limited-stage small-cell lung cancer, but the optimal radiotherapy schedule and dose ...

Radiotherapy With vs Without Chemoradiotherapy and Survival ...

Concurrent chemoradiotherapy is recommended for patients with stage II nasopharyngeal carcinoma (NPC) based on a single randomized clinical ...

Original Article Treatment Variation of Sequential versus Concurrent ...

Concurrent chemoradiotherapy (CCRT) is considered the standard treatment regimen in non-surgical locally advanced non-small cell lung cancer (NSCLC) ...

Concurrent Chemotherapy and Short Course Radiotherapy in ...

Upfront chemotherapy combined with palliative radiotherapy (30 Gy) is a promising treatment option in the subpopulation of patients with stage IIIA to IIIB ...

Practical implications to contemplate when considering radical ...

The type of patients with stage III non-small-cell lung cancer (NSCLC) selected for concurrent chemoradiotherapy (cCRT) varies between and ...

Chemoradiotherapy in Cancer Treatment: Rationale and Clinical ...

concurrent chemoradiation in patients with stage III unresectable non-small cell lung cancer (PACIFIC) - ClinicalTrials.gov. Available at ...

Rationale for concurrent chemoradiotherapy for patients with stage ...

AbstractWhen treating patients with unresectable stage III non-small-cell lung cancer (NSCLC), those with a good performance status and disease measured ...

Cons: concurrent chemo-radiotherapy remains the ideal treatment in ...

The patient rationale for this potential decision is to potentially reduce treatment related toxicity but maintain the opportunity for other ...

Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II ...

Concurrent chemoradiotherapy (CCRT) has been shown to improve outcomes for stage III–IV nasopharyngeal carcinoma (NPC) patients compared with radiotherapy (RT) ...